In fact, STING drop-out prevented the activation of IFNA1, IFNB1, and CXCL9 gene transcription by BTZ and abolished the capacity of BTZ-treated human MM cells to stimulate CD4+ EM and CD8+ EM cells in co-cultured immune cells. This evidence concerns the gene CD8A and Miyoshi myopathy.